Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 981

1.

Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.

Chang WC, Chang YH, Pan CC.

Am J Surg Pathol. 2012 Mar;36(3):454-61. doi: 10.1097/PAS.0b013e31823dafd3.

PMID:
22261706
2.

Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.

Patriarca C, Hurle R, Moschini M, Freschi M, Colombo P, Colecchia M, Ferrari L, Guazzoni G, Conti A, Conti G, Lucianò R, Magnani T, Colombo R.

Diagn Pathol. 2016 Jan 20;11:6. doi: 10.1186/s13000-016-0466-6.

3.
5.

Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.

Hu Z, Mudaliar K, Quek ML, Paner GP, Barkan GA.

Ann Diagn Pathol. 2014 Apr;18(2):49-52. doi: 10.1016/j.anndiagpath.2013.11.002. Epub 2013 Nov 20.

PMID:
24370460
6.

Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.

Toll AD, Epstein JI.

Am J Surg Pathol. 2012 Jul;36(7):1081-6. doi: 10.1097/PAS.0b013e318253d6e0.

PMID:
22510761
7.

Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.

Orsola A, Trias I, Raventós CX, Español I, Cecchini L, Búcar S, Salinas D, Orsola I.

Eur Urol. 2005 Aug;48(2):231-8; discussion 238.

PMID:
15963635
8.
9.

Expectant management of small, recurrent, noninvasive papillary bladder tumors.

Soloway MS, Bruck DS, Kim SS.

J Urol. 2003 Aug;170(2 Pt 1):438-41.

PMID:
12853794
10.

Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.

Reis LO, Taheri D, Chaux A, Guner G, Mendoza Rodriguez MA, Bivalacqua TJ, Schoenberg MP, Epstein JI, Netto GJ.

Hum Pathol. 2016 Jan;47(1):20-5. doi: 10.1016/j.humpath.2015.09.007. Epub 2015 Sep 25.

PMID:
26520419
11.

Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.

Bol MG, Baak JP, Buhr-Wildhagen S, Kruse AJ, Kjellevold KH, Janssen EA, Mestad O, Øgreid P.

J Urol. 2003 Apr;169(4):1291-4.

PMID:
12629345
12.

Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.

Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.

J Urol. 2008 Nov;180(5):1928-32; discussion 1932. doi: 10.1016/j.juro.2008.07.056. Epub 2008 Sep 17.

PMID:
18801529
14.

Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression.

Chen PC, Yu HJ, Chang YH, Pan CC.

J Clin Pathol. 2013 Feb;66(2):113-9. doi: 10.1136/jclinpath-2012-200944. Epub 2012 Oct 19.

PMID:
23087329
15.

Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system.

Nishiyama N, Kitamura H, Maeda T, Takahashi S, Masumori N, Hasegawa T, Tsukamoto T.

Jpn J Clin Oncol. 2013 Nov;43(11):1124-31. doi: 10.1093/jjco/hyt120. Epub 2013 Aug 26.

PMID:
23980236
16.

Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.

Paner GP, Barkan GA, Mehta V, Sirintrapun SJ, Tsuzuki T, Sebo TJ, Jimenez RE.

Am J Surg Pathol. 2012 Mar;36(3):432-42. doi: 10.1097/PAS.0b013e31823fe49c. Review.

PMID:
22301493
17.

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.

Urology. 2007 Sep;70(3):482-6.

PMID:
17905101
18.

Significance of denuded urothelium in papillary urothelial lesions.

Owens CL, Epstein JI.

Am J Surg Pathol. 2007 Feb;31(2):298-303.

PMID:
17255776
19.

Significance of random bladder biopsies in superficial bladder cancer.

May F, Treiber U, Hartung R, Schwaibold H.

Eur Urol. 2003 Jul;44(1):47-50.

PMID:
12814674
20.

External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.

Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, Tilki D, Trojan L, Perrotte P, Haferkamp A, Hohenfellner M, Wieland WF, Müller SC, Karakiewicz PI, Bastian PJ.

Eur Urol. 2012 Jan;61(1):58-64. doi: 10.1016/j.eururo.2011.07.066. Epub 2011 Aug 9.

PMID:
21840642

Supplemental Content

Support Center